
ALT Image of a document titled "New Warning for GLP-1 Receptor Agonists." The text discusses an FDA warning about nonarteritic anterior ischemic optic neuropathy (NAION) associated with GLP-1 receptor agonists like Trulicity, Byetta, and others. It covers NAION by reduced blood flow to the optic nerve and lists certain risk factors. The document includes a mechanism explanation, statistical data, and recommendations for healthcare professionals to consider before prescribing these medications.

ALT Table listing some long-acting injectable second-generation antipsychotics, including their names, formulations, usual adult maintenance dosages, and costs. Examples are Aripiprazole, Olanzapine, Paliperidone Palmitate, and Risperidone. Details include specific brands and injection schedules. Additional footnotes provide dosage adjustment information based on individual responses.

ALT Table illustrating FDA-cleared plasma biomarker tests for Alzheimer's Disease. The table includes columns for manufacturer, biomarkers measured, application, test method, result interpretation, and comments for three tests: Elecsys Phospo-Tau (181P) by Roche, Elecsys Phospo-Tau (217P) and Lumipulse G by Fujirebio, and PrecivityAD by C2N Diagnostics. Each test is detailed with its specific biomarker, intended use, method, interpretive results, and general comments.

















